Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2010; 135(48): 2417-2419
DOI: 10.1055/s-0030-1247875
DOI: 10.1055/s-0030-1247875
Aktuelle Diagnostik & Therapie | Review article
Hypertensiologie, Diabetologie© Georg Thieme Verlag KG Stuttgart · New York
Neue Zielblutdruckwerte in der antihypertensiven Therapie diabetischer Patienten?
New targets for blood pressure lowering in diabetic patients?Further Information
Publication History
eingereicht: 13.9.2010
akzeptiert: 21.10.2010
Publication Date:
16 November 2010 (online)

Schlüsselwörter
Diabetes - Hypertonie - Blutdrucksenkung - Zielwerte
Keywords
diabetes - hypertension - blood pressure lowering - target values
Literatur
- 1
The ACCORD Study
Group .
Effects of intensive blood-pressure control in
type 2 diabetes mellitus.
N Engl J Med.
2010;
362
1575-1585
MissingFormLabel
- 2
Berthold H K, Gouni-Berthold I, Bestehorn K P, Bohm M, Krone W.
Kardiovaskuläre Risikofaktoren bei Typ-2-Diabetikern
in Deutschland – ein Versorgungsparadox.
Dtsch Ärztebl.
2007;
104
A861-867
MissingFormLabel
- 3
Cooper-DeHoff R M, Gong Y, Handberg E M. et al .
Tight blood pressure
control and cardiovascular outcomes among hypertensive patients
with diabetes and coronary artery disease.
J Amer Med
Ass.
2010;
304
61-68
MissingFormLabel
- 4
Kannel W B, Wilson P W, Zhang T J.
The epidemiology of impaired glucose tolerance
and hypertension.
Am Heart J.
1991;
121
1268-1273
MissingFormLabel
- 5
Mancia G, De Backer G, Dominiczak A. et al .
2007 Guidelines for the management of arterial
hypertension.
J Hypertens.
2007;
25
1105-1187
MissingFormLabel
- 6
Mancia G, Laurent S, Agabiti-Rosei E. et al .
Reappraisal of European guidelines on hypertension
management: a European Society of Hypertension Task Force document.
J Hypertens.
2009;
27
2121-2158
MissingFormLabel
- 7
Messerli F H, Mancia G, Conti C R. et al .
Dogma disputed: can aggressively lowering
blood pressure in hypertensive patients with coronary artery disease
be dangerous?.
Ann Intern Med.
2006;
144
884-893
MissingFormLabel
- 8
Patel A, MacMahon S, Chalmers J. et al .
Effects of a fixed combination of perindopril
and indapamide on macrovascular and microvascular outcomes in patients
with type 2 diabetes mellitus (the ADVANCE trial): a randomised
controlled trial.
Lancet.
2007;
370
829-840
MissingFormLabel
- 9
Patel A, MacMahon S, Chalmers J. et al .
Intensive blood glucose control and vascular
outcomes in patients with type 2 diabetes.
N Engl J Med.
2008;
358
2560-2572
MissingFormLabel
- 10
Ryden L, Standl E. et al .
Guidelines
on diabetes, pre-diabetes, and cardiovascular diseases: executive
summary.
Eur Heart J.
2007;
28
88-136
MissingFormLabel
- 11
Schrier R W, Estacio R O, Esler A, Mehler P.
Effects of aggressive
blood pressure control in normotensive type 2 diabetic patients
on albuminuria, retinopathy and strokes.
Kidney Int.
2002;
61
1086-1097
MissingFormLabel
- 12
Stamler J, Vaccaro O, Neaton J D, Wentworth D.
Diabetes, other risk
factors, and 12-yr cardiovascular mortality for men screened in
the Multiple Risk Factor Intervention Trial.
Diabetes
Care.
1993;
16
434-444
MissingFormLabel
- 13
Tarnow L, Rossing P, Gall M A, Nielsen F S, Parving H H.
Prevalence of arterial hypertension in diabetic
patients before and after the JNC-V.
Diabetes Care.
1994;
17
1247-1251
MissingFormLabel
- 14
UK Prospective Diabetes Study
Group .
Tight blood pressure control and risk of macrovascular
and microvascular complications in type 2 diabetes: UKPDS 38.
Brit Med J.
1998;
317
703-713
MissingFormLabel
Prof. Dr. med. Ulrich Kintscher
Center for Cardiovascular Research (CCR)
Institut
für Pharmakologie
Charité – Universitätsmedizin
Berlin
Hessische Str. 3–4
10115 Berlin
Phone: 030/450525276
Fax: 030/450525901
Email: ulrich.kintscher@charite.de